Biermasz, Nienke R <br/><br/>
Intravenous octreotide test predicts the long term outcome of treatment with octreotide-long-acting repeatable in active acromegaly.  [electronic resource] 

 -  Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society  Jun 2005 
 - 200-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1096-6374 
<br/><br/><label>Standard No.: </label>10.1016/j.ghir.2005.02.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acromegaly--diagnosis<br/>Adult<br/>Aged<br/>Biological Availability<br/>Female<br/>Human Growth Hormone--blood<br/>Humans<br/>Injections, Intravenous<br/>Male<br/>Middle Aged<br/>Octreotide--administration & dosage<br/>Pituitary Function Tests<br/>Prognosis<br/>Treatment Outcome